Search   
MSDS  : 19-Nor-17-alpha-pregn-4-en-20-yn-3-one, 17-hydroxy-, acetate mixed with 19-nor-17-alpha- pregna-1,3,5-(10)-trien-20-yne-3,17-diol
CAS  : 8015-12-1
SYNONYMS  : * Anovlar 21 * Controvlar * Ethinylestradiol and norethindrone acetate * Ethinyl oestradiol mixed with norethisterone acetate * Gyn-Anovlar * Gynonlar 21 * Minovlar * Norethindrone acetate and ethinylestradiol * Norethisterone acetate mixed with ethinyl oestradiol * Norlestrin * Primodos
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : RC8990000
CHEMICAL NAME : 19-Nor-17-alpha-pregn-4-en-20-yn-3-one, 17-hydroxy-,
acetate mixed with 19-nor-17-alpha-
pregna-1,3,5-(10)-trien-20-yne-3,17-diol
CAS REGISTRY NUMBER : 8015-12-1
LAST UPDATED : 199706
DATA ITEMS CITED : 21
MOLECULAR FORMULA : C22-H28-O3.C20-H24-O2
MOLECULAR WEIGHT : 636.94
COMPOUND DESCRIPTOR : Tumorigen
Drug
Mutagen
Reproductive Effector
Human
Hormone
SYNONYMS/TRADE NAMES :
* Anovlar 21
* Controvlar
* Ethinylestradiol and norethindrone acetate
* Ethinyl oestradiol mixed with norethisterone acetate
* Gyn-Anovlar
* Gynonlar 21
* Minovlar
* Norethindrone acetate and ethinylestradiol
* Norethisterone acetate mixed with ethinyl oestradiol
* Norlestrin
* Primodos

*** HEALTH HAZARD DATA ***

** TUMORIGENIC DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - woman
DOSE/DURATION : 23562 ug/kg/94W-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria
Lungs, Thorax, or Respiration - tumors
Liver - tumors
REFERENCE :
LANCAO Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823-
Volume(issue)/page/year: 1,207,1978

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 11087 mg/kg/1Y-C
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Liver - tumors
REFERENCE :
KNZOAU Kanzo. Liver. (Nippon Kanzo Gakkai, c/o Kikka Bldg., 4-1-1 Hongo,
Bunkyo-ku, Tokyo 113, Japan) V.1- 1960- Volume(issue)/page/year:
23,57,1982

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 69 mg/kg/69W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Skin and Appendages - tumors
Blood - leukemia
REFERENCE :
PEXTAR Progress in Experimental Tumor Research. (S. Karger AG, Postfach
CH-4009 Basel, Switzerland) V.1- 1960- Volume(issue)/page/year:
11,440,1969

TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - woman
DOSE/DURATION : 41 mg/kg/2Y-I
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria
Liver - tumors
REFERENCE :
MJAUAJ Medical Journal of Australia. (Australasian Medical Pub. Co. Ltd.,
71-79 Arundel St., Glebe, N.S.W., Australia) V.1- 1914-
Volume(issue)/page/year: 2,223,1978

TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 22174 mg/kg/1Y-C
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Liver - tumors
REFERENCE :
KNZOAU Kanzo. Liver. (Nippon Kanzo Gakkai, c/o Kikka Bldg., 4-1-1 Hongo,
Bunkyo-ku, Tokyo 113, Japan) V.1- 1960- Volume(issue)/page/year:
23,57,1982

TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - woman
DOSE/DURATION : 81 mg/kg/8Y-I
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria
Liver - tumors
REFERENCE :
BMJOAE British Medical Journal. (British Medical Assoc., BMA House,
Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year:
3,7,1974

TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 11087 mg/kg/1Y-C
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Liver - tumors
REFERENCE :
GANNA2 Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75,
1907-84. For publisher information, see JJCREP. Volume(issue)/page/year:
71,576,1980

** REPRODUCTIVE DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - woman
DOSE : 1176 ug/kg
SEX/DURATION : lactating female 56 day(s) post-birth
TOXIC EFFECTS :
Reproductive - Maternal Effects - postpartum
REFERENCE :
IJMRAQ Indian Journal of Medical Research. (Indian Council of Medical
Research, Ansari Nagar, New Delhi 110 029, India) V.1- 1913-
Volume(issue)/page/year: 62,964,1974

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - woman
DOSE : 420 ug/kg
SEX/DURATION : female 20 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Maternal Effects - menstrual cycle changes or disorders
REFERENCE :
CCPTAY Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1-
1970- Volume(issue)/page/year: 26,23,1982

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - woman
DOSE : 214 ug/kg
SEX/DURATION : female 20 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Fertility - other measures of fertility
REFERENCE :
CCPTAY Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1-
1970- Volume(issue)/page/year: 25,463,1982

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - woman
DOSE : 9720 ug/kg
SEX/DURATION : female 26 week(s) pre-mating
TOXIC EFFECTS :
Reproductive - Fertility - female fertility index (e.g. # females pregnant
per # sperm positive females; # females pregnant per # females mated)
REFERENCE :
BMJOAE British Medical Journal. (British Medical Assoc., BMA House,
Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year:
2,75,1962

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - woman
DOSE : 1620 ug/kg
SEX/DURATION : female 20 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Fertility - female fertility index (e.g. # females pregnant
per # sperm positive females; # females pregnant per # females mated)
REFERENCE :
JRPFA4 Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot,
POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960-
Volume(issue)/page/year: 4,229,1962

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - woman
DOSE : 401 ug/kg
SEX/DURATION : female 5 week(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System
REFERENCE :
NATUAS Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736)
V.1- 1869- Volume(issue)/page/year: 216,83,1967

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Primate - monkey
DOSE : 14280 ug/kg
SEX/DURATION : female 33-46 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death
REFERENCE :
TJADAB Teratology, The International Journal of Abnormal Development. (Alan
R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968-
Volume(issue)/page/year: 21,44A,1980

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Primate - monkey
DOSE : 15300 ug/kg
SEX/DURATION : female 21-35 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - abortion
REFERENCE :
TJADAB Teratology, The International Journal of Abnormal Development. (Alan
R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968-
Volume(issue)/page/year: 27,215,1983

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Primate - monkey
DOSE : 24 mg/kg
SEX/DURATION : female 23-46 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - behavioral
REFERENCE :
NTOTDY Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8,
1981-86. For publisher information, see NETEEC. Volume(issue)/page/year:
5,301,1983

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Primate - monkey
DOSE : 621 mg/kg
SEX/DURATION : female 20-50 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death
REFERENCE :
TJADAB Teratology, The International Journal of Abnormal Development. (Alan
R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968-
Volume(issue)/page/year: 35,119,1987

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Primate - monkey
DOSE : 1864 mg/kg
SEX/DURATION : female 20-50 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - urogenital system
REFERENCE :
TJADAB Teratology, The International Journal of Abnormal Development. (Alan
R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968-
Volume(issue)/page/year: 35,119,1987

** MUTATION DATA **

TYPE OF TEST : Cytogenetic analysis
ROUTE OF EXPOSURE : Oral
TEST SYSTEM : Rodent - mouse
DOSE/DURATION : 12 mg/kg/15D (Continuous)
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE
Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 260,47,1991

*** REVIEWS ***

TOXICOLOGY REVIEW
TJADAB Teratology, The International Journal of Abnormal Development. (Alan
R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968-
Volume(issue)/page/year: 21,225,1980

*** STATUS IN U.S. ***

EPA GENETOX PROGRAM 1988, Negative: Rodent dominant lethal


*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
Oils, soya bean, epoxidised 8006-87-9
Oils, spruce 8008-80-8
1-alpha-H,5-alpha-H-Nortropan-3-alpha-ol, 8-allyl-,benzilate (ester), hydrochloride 8008-80-8
Oils, tea-tree 68647-73-4
Oils, sweet birch 68917-50-0
Oils, verbena 8024-12-2
Oils, wheat germ 68917-73-7
Oils, wormseed 68917-73-7
Oil of Thymus kotschyanus 68917-73-7
Oil Yellow HA 6370-43-0
OKY-500 6370-43-0
Olax acuminata Benth., extract excluding rootsSUBSTANCE DEFINITION :Plant belonging to the family OlacaceaeREFERENCE :IJEBA6 Indian Journal of Experimental Biology. (Publications & InformationDirectorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963-Volume(issue)/page/year: 26,883,1988 6370-43-0
Olax scandens Roxb., extract excluding rootsSUBSTANCE DEFINITION :Plant belonging to the family OlacaceaeREFERENCE :IJEBA6 Indian Journal of Experimental Biology. (Publications & InformationDirectorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- 6370-43-0
(+)-2-alpha-Nortropan-2-ol, 8-allyl-,diphenylglycolate 74080-87-8
Olax wightiana Wall., extract excluding rootsSUBSTANCE DEFINITION :Plant belonging to the family OlacaceaeREFERENCE :IJEBA6 Indian Journal of Experimental Biology. (Publications & InformationDirectorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963-Volume(issue)/page/year: 12,512,1974 74080-87-8
Oldenlandia articularis Gamble, extract excludingrootsSUBSTANCE DEFINITION :Plant belonging to the family RubiaceaeREFERENCE :IJEBA6 Indian Journal of Experimental Biology. (Publications & InformationDirectorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963-Volume(issue)/page/year: 12,512,1974 74080-87-8
Oldenlandia corymbosa Linn., extractSUBSTANCE DEFINITION :Plant belonging to the family RubiaceaeREFERENCE :IJEBA6 Indian Journal of Experimental Biology. (Publications & InformationDirectorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- 74080-87-8
Olea europea, extract 74080-87-8
Olean-12-en-28-oic acid, 3,23-dihydroxy-,(3-beta,4-alpha)- 465-99-6
Olean-29-al,13,28-epoxy-3-((O-beta-D-glucopyranosyl-(1-3)-O-(beta-D-xylopyranosyl-(1-2 ))-O-beta-D-glucopyranosyl-(1-4)-O-(beta-D-glucopyranosyl-(1-2))-alpha-L-arabin opyranosyl)oxy)- 16-hydroxy-,(3-beta,16-alpha,20-beta)- 23643-76-7
Oleandomycin 3922-90-5
Oleandomycin, mixt. with(4S-(4-alpha,4a-alpha,5a-alpha,6-beta,12a-alpha))-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-N-(4-mo rpholinylmethyl)-1,11-dioxo-2-naphthacenecarboxamide 18353-77-0
Oleandomycin, phosphate (11) (salt) 7060-74-4
Oleandomycin, triacetate (ester) 2751-09-9
3-Nortropanol, 8-benzyl-3-(p-chlorophenyl)-, oxalate 101858-20-2
Oleandra pistillaris (sw.) C.Chr., extractSUBSTANCE DEFINITION :Plant belonging to the family OleandraceaeREFERENCE :IJEBA6 Indian Journal of Experimental Biology. (Publications & InformationDirectorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- 101858-20-2
Olean-12-ene-28,29-dioic acid,2,23-dihydroxy-3-((4-O-beta-D-glucopyranosyl-beta-D-xylopyranosyl)oxy)-, 29-methyl ester,(2-beta,3-beta,4-alpha,20-beta)- 65497-07-6
Olean-12-ene-28,29-dioic acid,2,23-dihydroxy-3-(beta-D-xylopyranosyloxy)-,29-methyl ester, (2-beta,3-beta,4-alpha,20-beta)- 60820-94-2
Olean-12-ene-3,29-diol, (3-beta,20-beta)- 6813-59-8
Olean-12-en-29-oic acid, 3-(acetyloxy)-11-oxo-,(3-beta,20-beta)- 6277-14-1
Olean-12-en-29-oic acid, 3-(acetyloxy)-11-oxo-,aluminum salt, (3-beta,20-beta)- 29728-34-5
Olean-12-en-28-oic acid,3-beta-((O-L-arabinopyranosyl-(1-3)-O-(O-D-galactopyranosyl-(1-4)-D-glucopyranosyl-(1-4))-D-glucopyranuronosyl)oxy)-23-oxo-, O-D-xylopyranosyl-(1-3)-O-6-deoxy-D-galactopyranosyl-(1-4)-O-(O-D-xylopyranosyl-(1-3)-D-xylopyranosyl- (1-2))-6-deoxy-L-mannopyranosyl ester 15588-68-8
Olean-12-en-28-oic acid,3-((2-O-(6-deoxy-alpha-L-mannopyranosyl)-alpha-L-arabinopyranosyl) oxy)-23-hydroxy-, (3-beta,4-alpha)- 27013-91-8
Olean-12-en-28-oic acid,3-((O-beta-D-galactopyranosyl-(1-3)-O-(beta-D-glucopyranosyl- (1-4))-beta-D-glucopyranosyl)oxy)-,(3-beta)- 53043-29-1
Olean-12-en-28-oic acid,3-((4-O-beta-D-galactopyranosyl-beta-D-glucopyranosyl)oxy), alpha-D- glucopyranosyl ester, (3-beta)- 34381-98-1
19-Nor-17-alpha-pregn-4-en-20-yn-3-one, 17-hydroxy-,acetate mixed with 19-nor-17-alpha-pregna-1,3,5-(10)-trien-20-yne-3,17-diol 8015-12-1
Nortropan-3-ol, 8-benzyl-3-(p-tolyl)- 101858-21-3
Olean-12-en-28-oic acid,3-((O-beta-D-glucopyranosyl-(1-2)-O-(beta-D-glucopyranosyl-(1-4))- beta-D-glucopyranosyl)oxy)-, (3-beta)- 50657-29-9
Olean-12-en-28-oic acid,3-beta-(beta-D-glucopyranosyloxy)- 3391-80-8
Olean-12-en-28-oic acid, 3-hydroxy-, (3-beta)- 508-02-1
Olean-12-en-28-oic acid, 3-beta-hydroxy-,2-(dimethylamino)ethyl ester, hydrochloride 508-02-1
Olean-12-en-30-oic acid, 3-beta-hydroxy-, hydrogenmaleate (ester), sodium salt 85559-57-5
Olean-12-en-28-oic acid, 3-beta-hydroxy-23-oxo- 639-14-5
Olean-12-en-30-oic acid, 3-beta-hydroxy-11-oxo- 471-53-4
18-alpha-Olean-12-en-30-oic acid,3-beta-hydroxy-11-oxo- 1449-05-4
Olean-12-en-30-oic acid, 3-beta-hydroxy-11-oxo-,hydrogen succinate 5697-56-3
Olean-12-en-30-oic acid, 3-beta-hydroxy-11-oxo-,hydrogen succinate, disodium salt 7421-40-1
1-alpha-H,5-alpha-H-Nortropan-3-beta-ol,8-(3-(2-chlorophenothiazin-10-yl)propyl)- 73805-93-3
Olean-12-en-28-oic acid, 22-beta-hydroxy-3-oxo-,2-methylcrotonate, (Z)- 467-81-2
Olean-12-en-28-oic acid, 22-beta-hydroxy-3-oxo-,3-methylcrotonate 467-82-3

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net